Strategies Needed to Improve Delivery of Alzheimer Disease-Modifying Therapies

Follow Drugslib on

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

TUESDAY, Jan. 30, 2024 -- Strategies are needed to improve the delivery of Alzheimer disease (AD) disease-modifying therapies (DMTs), according to a report published online Jan. 30 by the RAND Corporation.

Jodi L. Liu, Ph.D., from the RAND Corporation in Santa Monica, California, and colleagues used a simulation model to examine how primary care capacity for early detection impacts the delivery of AD DMTs, taking into account geographic variation in patient populations and health system capacities.

The researchers note that across the United States, there is considerable variation in health care system capacity to detect, diagnose, and treat early-stage AD with DMTs. Estimated wait times and the number of patients treated are sensitive to the uptake of brief cognitive assessments. There was variation observed by state in the estimated average wait times, and these wait times could be three times longer in rural versus urban areas. According to the researchers, the biggest impact on reducing wait times for specialists would be with implementation of care models that enable primary care practitioners to diagnose and evaluate patients for treatment eligibility; this implementation would also have the largest impact on increasing the number of people treated from 2025 through 2044. Caseloads for specialists could be further reduced by improved triage of patients using blood-based biomarker tests. A combination of strategies to communicate the value of detection and treatment of patients, integrate primary care practitioners into the detection and diagnosis pathway, and address capacity disparities are required for widespread delivery of AD DMTs.

"Our analysis suggests that strategies are needed to ease the demand on specialists for evaluation and diagnosis of cognitive impairment," Liu said in a statement.

More Information

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-01-31 02:15

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords